Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells

Although docetaxel-based regimens are common and effective for early-stage triple-negative breast cancer (TNBC) treatment, acquired drug resistance frequently occurs. Therefore, a novel therapeutic strategy for docetaxel-resistant TNBC is urgently required. Signal transducer and activator of transcr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biomedicines
Päätekijät: Byun, Woong Sub, Bae, Eun Seo, Cui, Jinsheng, Park, Hyen Joo, Oh, Dong-Chan, Lee, Sang Kook
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8074004/
https://ncbi.nlm.nih.gov/pubmed/33920736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040436
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia